IQVIA Holdings Inc
NYSE:IQV

Watchlist Manager
IQVIA Holdings Inc Logo
IQVIA Holdings Inc
NYSE:IQV
Watchlist
Price: 201.82 USD 2.14% Market Closed
Market Cap: 36.7B USD
Have any thoughts about
IQVIA Holdings Inc?
Write Note

Operating Margin
IQVIA Holdings Inc

14.1%
Current
13%
Average
2.4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
14.1%
=
Operating Profit
2.2B
/
Revenue
15.3B

Operating Margin Across Competitors

Country US
Market Cap 36.7B USD
Operating Margin
14%
Country US
Market Cap 1.3T USD
Operating Margin
14%
Country US
Market Cap 196.3B USD
Operating Margin
17%
Country US
Market Cap 170.3B USD
Operating Margin
21%
Country KR
Market Cap 66.5T KRW
Operating Margin
31%
Country CH
Market Cap 37.6B CHF
Operating Margin
13%
Country US
Market Cap 38.5B USD
Operating Margin
25%
Country US
Market Cap 26.4B USD
Operating Margin
28%
Country US
Market Cap 23B USD
Operating Margin
20%
Country US
Market Cap 22.3B USD
Operating Margin
8%
Country US
Market Cap 22.2B USD
Operating Margin
29%
No Stocks Found

IQVIA Holdings Inc
Glance View

Market Cap
36.7B USD
Industry
Life Sciences Tools & Services

IQVIA Holdings Inc. stands at the crossroads of healthcare and technology, blending innovative data analytics with deep industry expertise to enhance the clinical development and commercialization of pharmaceuticals. Founded in 2016 from the merger of IMS Health and Quintiles, IQVIA has rapidly positioned itself as a leader within the life sciences sector. The company's core mission revolves around leveraging vast sources of healthcare data and advanced artificial intelligence to provide actionable insights, streamline drug development processes, and facilitate improved patient outcomes. With a global footprint extending across more than 100 countries, IQVIA serves a diverse clientele, including biopharmaceutical companies, healthcare providers, and government organizations, making it a pivotal player in the ever-evolving healthcare landscape. For investors, IQVIA represents a compelling opportunity that combines robust financial performance with strong market demand driven by the growing complexities of drug development and regulatory environments. As the healthcare sector increasingly turns to data-driven decision-making, IQVIA's extensive suite of services—including real-world evidence, market access solutions, and technology-enabled clinical trial services—positions it favorably in a market ripe for innovation. The company's commitment to research and development, coupled with strategic partnerships and acquisitions, fuels its long-term growth trajectory. Furthermore, IQVIA's resilience in navigating industry shifts, highlighted by its consistent revenue growth and healthy profit margins, reflects a business model that is not only scalable but also agile enough to adapt to the challenges and opportunities of modern medicine.

IQV Intrinsic Value
259.71 USD
Undervaluation 22%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
14.1%
=
Operating Profit
2.2B
/
Revenue
15.3B
What is the Operating Margin of IQVIA Holdings Inc?

Based on IQVIA Holdings Inc's most recent financial statements, the company has Operating Margin of 14.1%.